ESMO Congress 2026

October 23–27, 2026 · Madrid · 176 items

Madrid floor. One post is one item; several people on the same trial or drug become a heat probe. The floor is paged by day; prelude discussion sits on the prelude board. Abstracts are linked, not reprinted, and other people's slides are not posted.

Oct 19Mon

Monday · 9 items

16:55
DaisukeKotani@DaisukeKotaniScore6060
#ESMO26 | 787RO BRICKET: Ph2 re-treatment with EC in BRAF V600E mCRC @myESMO @OncoAlert
787RO BRAFHeat 118 likes0 replies3 reposts
16:24
dr_yakupergun@dr_yakupergunScore6060
#ESMO26 | DESTINY-Breast11 MRI Analysis At cycle 4, ORR was 77.3% in the T-DXd→THP arm vs 50.8% in the ddAC→THP arm. Among patients who achieved CR, PR, or no objective response …
DESTINY-BREAST11Heat 5743 likes0 replies14 reposts
13:52
ozdogan_md@ozdogan_mdScore6060
Five Phase 3 Trials to Watch at ESMO 2026 Positive toplines are in for INTerpath-001, VOLGA, DeLLphi-305, KRAScendo 1 and SAFFRON. Madrid must now show the effect sizes: HRs, abso…
Same topic INTERPATH-001 · 11 people VOLGA DELLPHI-305 KRASCENDO SAFFRONHeat 52 likes0 replies3 reposts
08:01
TapiaJC1@TapiaJC1Score6060
#ESMO26 1003O: Ph1 study of IM96, a #GCC-targeted #CART therapy, in heavily pre-treated #CRC (4L+). ORR 42%, with G3 CRS in 10%. Promising efficacy in a setting with few options…
1003O #GCC-TARGETED #CART #COLONCANCERHeat 00 likes0 replies0 reposts
07:04
dr_yakupergun@dr_yakupergunScore6060
In another meta-analysis of ours, to be presented at #ESMO26 , we evaluated whether adding carboplatin to taxane plus dual HER2 blockade improves pCR rates in neoadjuvant HER2+ bre…
Same topic HER2 · 3 peopleHeat 3628 likes0 replies8 reposts
07:00
DaisukeKotani@DaisukeKotaniScore6060
#ESMO26 | 3530O UNION: Ph3 neoadjuvant SCRT followed by camrelizumab + chemo in locally advanced rectal cancer - 3y-EFS: 91.3% vs 77.4%, HR 0.33, p=0.0029 👉UNION is the first Ph3 …
Same topic UNION · 3 people 3530O camrelizumabHeat 117 likes0 replies4 reposts
06:59
dr_yakupergun@dr_yakupergunScore6060
#ESMO26 Abstracts Are Out! In our meta-analysis with the @OncBrothers (Rohit and Rahul), we compared first-line BRAF/MEK inhibitors with ICI-based regimens in BRAF V600E-mutant aN…
BRAF MEKHeat 6048 likes0 replies12 reposts
06:36
DaisukeKotani@DaisukeKotaniScore6060
#ESMO26 | 2875O KEYNOTE-975 Pembro or placebo + dCRT in esophageal cancer - EFS: HR 0.97 (CPS ≥10) - OS: HR 1.00 (CPS ≥10) @myESMO @OncoAlert
Same topic KEYNOTE-975 · 3 people 2875OHeat 2617 likes0 replies9 reposts
03:20
nicolobattisti@nicolobattistiScore6060
#ESMO26 breast cancer: my ten to watch OS from NATALEE, postMONARCH and FINER. CDK4 with FOURLIGHT-1. Pembro in HR+ with KEYNOTE-B49. T-DXd moves neoadjuvant in TALENT. ADC after …
Same topic NATALEE · 4 people POSTMONARCH FOURLIGHT-1 KEYNOTE-B49 #BREASTCANCERHeat 10 likes0 replies1 repost

Oct 18Sun

Sunday · 2 items

19:01
LungSummit@LungSummitScore6060
Sigvotatug vedotin vs docetaxel in pretreated nonsquamous NSCLC: Pfizer said in June the phase 3 missed its OS endpoint. Our faculty member Solange Peters (@peters_solange) present…
LBA68 docetaxelHeat 108 likes0 replies2 reposts
05:42
Kenrickng1@Kenrickng1Score6060
1/ 🧵 My prostate cancer picks for #ESMO26 - a thread Presidential session: DASL-HiCaP (LBA4, Sun 25 Oct, 16:30): intensified AR-targeted therapy with RT in very high-risk localise…
Same topic DASL-HICAP · 3 people LBA4 2215OHeat 2519 likes0 replies6 reposts

Oct 17Sat

Saturday · 1 items

19:01
LungSummit@LungSummitScore6060
Tarlatamab + durvalumab as 1L maintenance in ES-SCLC: DeLLphi-305 met its OS endpoint at an interim analysis, Amgen said on 8 Sep. Our faculty member Jacob Sands (@sands_jacob) pre…
Same topic DELLPHI-305 · 5 people LBA3 tarlatamab durvalumab METHeat 76 likes0 replies1 repost

Oct 16Fri

Friday · 3 items

21:22
TheGutOncLab@TheGutOncLabScore6060
@GIMedOnc with the GI oncology abstracts that he’s most excited about at #ESMO26 👇
Heat 44 likes0 replies0 reposts
05:07
OncLive@OncLiveScore6060
@BalazsHalmosMD and @DylanFortman preview 14 lung cancer abstracts at #ESMO26, including DeLLphi-305 (LBA3), Krascendo 1 (LBA5), SAFFRON (LBA6), OptiTROP-Lung06 (LBA66), and PERSEE…
Same topic DELLPHI-305 · 5 people KRASCENDO SAFFRON LBA3 LBA5 LBA6 LBA66 2614O #LCSMHeat 21 like0 replies1 repost
04:22
GrupoGetne@GrupoGetneScore6060
⏳ 1 week to #ESMO26 🇪🇸 📍 Madrid | 23–27 October 🧬 Neuroendocrine & endocrine tumors 📚 Some of the studies I’ll be following closely at #ESMO26
Heat 1410 likes0 replies4 reposts

Oct 15Thu

Thursday · 11 items

22:27
DCockrellMD@DCockrellMDScore6060
4/4 Lastly, a personal connection at #ESMO26 in #ProstateCancer. 🧬 #JNJ6143, formerly #HLD0915 — 2216O - Updated data for a novel treatment mechanism with an oral AR-targeted #RIP…
2216O #PROSTATECANCER #JNJ6143 #HLD0915 #RIPTACHeat 53 likes0 replies2 reposts
22:18
DCockrellMD@DCockrellMDScore6060
3/4 #KidneyCancer at #ESMO26 🟠 #LITESPARK011 — 3587O, 3595RO - Belzutifan + lenvatinib improved PFS vs cabo after IO (14.8 vs 10.7 mo; HR 0.70), leading to September FDA approval.…
3587O 3595RO 3586O lenvatinib #KIDNEYCANCER #LITESPARK011 #LITESPARK012 #PAPMET2Heat 22 likes0 replies0 reposts
22:15
DCockrellMD@DCockrellMDScore6060
2/4 #BladderCancer at #ESMO26 🟢 #VOLGA — LBA2 - Positive EFS/OS topline announced for durva + EV. Looking for the magnitude of benefit, surgical outcomes, and toxicity. - We know …
Same topic VOLGA · 6 people LBA2 4734O pembrolizumab #BLADDERCANCER #VOLGA #KEYNOTEB15 #CTDNAHeat 43 likes0 replies1 repost
22:10
DCockrellMD@DCockrellMDScore6060
1/4 #ESMO26 GU preview: a few studies I’ll be watching next week, starting with #ProstateCancer. 👇 🔵 #DASLHiCaP — LBA4 - Darolutamide + ADT + definitive/salvage RT in very-high-ri…
LBA4 LBA53 #PROSTATECANCER #DASLHICAP #PROTEUS #CAPITELLO281 #PEACE1Heat 1410 likes0 replies4 reposts
17:26
MarioBalsaMD@MarioBalsaMDScore6060
🚨 Excited to join the #ESMO26 @OncoAlert PULSE Faculty for melanoma & early drug development! 💥 My 10 trials to watch (pic 👇🏼) INTerpath-001 || MOIO || DeLLphi-305 || HARMONi-GI…
Same topic INTERPATH-001 · 11 people MOIO DELLPHI-305 HARMONI-GI1 KRASCENDO-1 CLARITY-GASTRIC HERIZON-GEA NATALEE SAFFRONHeat 2418 likes0 replies6 reposts
15:05
DraMartinezLago@DraMartinezLagoScore6060
⏳ 1 week to #ESMO26 🇪🇸 📍 Madrid | 23–27 October 🧬 Sarcoma 📚 Some of the studies I’ll be following closely at #ESMO26
Heat 85 likes0 replies3 reposts
15:02
DraMartinezLago@DraMartinezLagoScore6060
⏳ 1 week to #ESMO26 🇪🇸 📍 Madrid | 23–27 October 🧬 Colorectal cancer 📚 Some of the studies I’ll be following closely at #ESMO26 @OncoAlert
Heat 177 likes0 replies10 reposts
14:21
DraMartinezLago@DraMartinezLagoScore6060
⏳ 1 week to #ESMO26 🇪🇸 📍 Madrid | 23–27 October 🧬 Neuroendocrine & endocrine tumors 📚 Some of the studies I’ll be following closely at #ESMO26
Heat 2519 likes0 replies6 reposts
14:19
DraMartinezLago@DraMartinezLagoScore6060
⏳ 1 week to #ESMO26 🇪🇸 📍 Madrid | 23–27 October 🧬 Hepatobiliopancreatic cancers 📚 Some of the studies I’ll be following closely at #ESMO26 @OncoAlert
Heat 4831 likes0 replies17 reposts
13:44
DraMartinezLago@DraMartinezLagoScore6060
⏳ 1 week to #ESMO26 🇪🇸 📍 Madrid | 23–27 October 🧬 Gastroesophageal cancer 📚 Some of the studies I’ll be following closely at #ESMO26 @OncoAlert
Heat 1812 likes0 replies6 reposts
08:02
yaelwaknine@yaelwaknineScore6060
#ESMO26 is nearly here, and I'm hyped. Ten of 12 Presidential abstracts are expected to show primary endpoints met. Seven have declared a survival win, including the VOLGA trial no…
Same topic VOLGA · 6 people MET #MEDEDHeat 11 like0 replies0 reposts